PCN77 COST-EFFECTIVENESS ANALYSIS OF TEMSIROLIMUS VS. SUNITINIB MALATE IN POOR PROGNOSIS METASTATIC RENAL CELL CARCINOMA (MRCC) IN PORTUGAL
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74328-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)74328-X/fulltext
Title :
PCN77 COST-EFFECTIVENESS ANALYSIS OF TEMSIROLIMUS VS. SUNITINIB MALATE IN POOR PROGNOSIS METASTATIC RENAL CELL CARCINOMA (MRCC) IN PORTUGAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74328-X&doi=10.1016/S1098-3015(10)74328-X
First page :
Section Title :
Open access? :
No
Section Order :
252